|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||
| Portfolio company investments, at fair value: | ||||||||||||||||
| Non-controlled, non-affiliated Investments | ||||||||||||||||
| Non-controlled, affiliated Investments | ||||||||||||||||
| Controlled, affiliated Investments | ||||||||||||||||
| Total portfolio company investments, at fair value | ||||||||||||||||
| Short-term investments (amortized cost of $48,683 and $12,802) | ||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||
| Receivable for principal payments on investments | ||||||||||||||||
| Investments in money market funds (amortized cost of $25,184 and $25,409) | ||||||||||||||||
| Cash | ||||||||||||||||
| Deposits for investments | ||||||||||||||||
| Receivable for sales of investments | ||||||||||||||||
| Receivable for principal payments on investments | ||||||||||||||||
| Interest receivable | ||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||
| Total Assets | ||||||||||||||||
| Liabilities: | ||||||||||||||||
| Corporate Credit Facility (Note 6) | ||||||||||||||||
| Unamortized Subscription Credit Facility issuance costs | ||||||||||||||||
| Unamortized Corporate Credit Facility issuance costs | ||||||||||||||||
| Revolving Funding Facility (Note 6) | ||||||||||||||||
| Unamortized Revolving Funding Facility issuance costs | ||||||||||||||||
| Revolving Funding Facility II (Note 6) | ||||||||||||||||
| Unamortized Revolving Funding Facility II issuance costs | ||||||||||||||||
| Subscription Credit Agreement (Note 6) | ||||||||||||||||
| Notes (Note 6) | ||||||||||||||||
| Unamortized notes issuance costs | ||||||||||||||||
| Payable for investments purchased | ||||||||||||||||
| Capital payable (Note 11) | ||||||||||||||||
| Shares repurchased payable (Note 7) | ||||||||||||||||
| Distributions payable | ||||||||||||||||
| Management fee payable (Note 3) | ||||||||||||||||
| Incentive fee payable (Note 3) | ||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||
| Accrued excise tax expense | ||||||||||||||||
| Total Liabilities | ||||||||||||||||
| Net Assets: | ||||||||||||||||
| Common Shares, $0.001 par value; 100,000,000 shares authorized; 66,216,562 and 67,998,184 as of June 30, 2026 and December 31, 2025 respectively, issued and outstanding | ||||||||||||||||
| Additional paid-in capital | ||||||||||||||||
| Total distributable earnings (deficit) | ||||||||||||||||
| Total Net Assets | ||||||||||||||||
| Total Liabilities and Net Assets | ||||||||||||||||
| Net Asset Value Per Common Share (in Dollars per share) | ||||||||||||||||
Loading...
